**Summary of Diploma PLC Preliminary Results for FY25 (Year Ended 30 September 2025)**
Diploma PLC reported **very strong preliminary results for FY25**, exceeding expectations with robust performance across key metrics. Highlights include
**Revenue Growth**Reported revenue increased by **12% to £1,524.5m**, driven by **11% organic growth** (ahead of expectations) and **3% from acquisitions**, partially offset by FX.
**Profitability**Adjusted operating profit rose **20% to £342.7m**, with margins expanding by **160 basis points to 22.5%**, reflecting strong execution and a differentiated value-add model.
**Earnings**Adjusted EPS grew **21% to 176.0p**, and basic EPS increased **43% to 137.9p**, underscoring sustained earnings momentum.
**Cash Flow**Free cash flow improved **25% to £247.2m**, with a **105% conversion rate**, and leverage reduced to **0.8x** from 1.3x, highlighting financial strength.
**Dividend**Total dividend per share increased **5% to 62.3p**, in line with policy.
**Sector Performance**Controls led with **20% organic growth**, Seals improved **2%** (strong H2 recovery), and Life Sciences grew **6%** despite healthcare market challenges.
**Acquisitions**Completed **seven acquisitions** in FY25 (total £92m, 8x multiple) in strategic markets like aerospace, defence, and IVD, with a healthy pipeline.
**FY26 Guidance**Expect **6% organic revenue growth** (H1-weighted) and **operating margin maintained at ~22.5%**.
CEO Johnny Thomson emphasized the company’s **sustainable quality compounding**, strong portfolio diversity, and acquisition momentum, positioning Diploma well for future growth. The results were filed with the FCA and are available on the corporate website. A webcast and analyst presentation were scheduled for further details.
**Key Takeaways**Diploma PLC delivered exceptional FY25 results, driven by organic growth, margin expansion, and strategic acquisitions, with positive momentum into FY26.